SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer
12 Aug 2024 //
BUSINESSWIRE
SpyBiotech Completes Enrollment In SPYVLP01 Phase I Trial
23 Jul 2024 //
BUSINESSWIRE
SpyBiotech Appoints Keith Dewedoff As CFO
18 Jun 2024 //
PR NEWSWIRE
Spybiotech Oxford Ebv Partnership: Research And Development Collaboration
23 May 2024 //
BUSINESSWIRE
SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01
07 Dec 2023 //
BUSINESSWIRE
SpyBiotech Announces MHRA Clinical Trial Application Filing for SPYVLP01
20 Sep 2023 //
BUSINESSWIRE
SpyBiotech Receives Grant to Advance Novel SpyVector Platform
20 Mar 2023 //
BUSINESSWIRE
SpyBiotech Appoints Industry Veteran Eddie Gray as Chair of Board of Directors
13 Feb 2023 //
BUSINESSWIRE
SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies
18 Mar 2021 //
BUSINESSWIRE
SpyBiotech Licenses Selexis Best-in-Class Cell Line Development Technologies
18 Mar 2021 //
BUSINESSWIRE
3P and SpyBiotech Enter Vaccine Contract Manufacturing Agreement
26 Oct 2020 //
CONTRACTPHARMA